1. Home
  2. DSS vs SILO Comparison

DSS vs SILO Comparison

Compare DSS & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • SILO
  • Stock Information
  • Founded
  • DSS 1984
  • SILO 2010
  • Country
  • DSS United States
  • SILO United States
  • Employees
  • DSS N/A
  • SILO N/A
  • Industry
  • DSS Containers/Packaging
  • SILO Apparel
  • Sector
  • DSS Consumer Discretionary
  • SILO Consumer Discretionary
  • Exchange
  • DSS Nasdaq
  • SILO Nasdaq
  • Market Cap
  • DSS 7.3M
  • SILO 8.8M
  • IPO Year
  • DSS N/A
  • SILO N/A
  • Fundamental
  • Price
  • DSS $0.86
  • SILO $1.59
  • Analyst Decision
  • DSS
  • SILO
  • Analyst Count
  • DSS 0
  • SILO 0
  • Target Price
  • DSS N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • DSS 19.0K
  • SILO 598.0K
  • Earning Date
  • DSS 03-26-2025
  • SILO 02-18-2025
  • Dividend Yield
  • DSS N/A
  • SILO N/A
  • EPS Growth
  • DSS N/A
  • SILO N/A
  • EPS
  • DSS N/A
  • SILO N/A
  • Revenue
  • DSS $25,019,000.00
  • SILO $72,102.00
  • Revenue This Year
  • DSS N/A
  • SILO $1.86
  • Revenue Next Year
  • DSS N/A
  • SILO N/A
  • P/E Ratio
  • DSS N/A
  • SILO N/A
  • Revenue Growth
  • DSS N/A
  • SILO N/A
  • 52 Week Low
  • DSS $0.77
  • SILO $0.77
  • 52 Week High
  • DSS $2.30
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • DSS 46.46
  • SILO 52.57
  • Support Level
  • DSS $0.85
  • SILO $1.56
  • Resistance Level
  • DSS $0.97
  • SILO $1.89
  • Average True Range (ATR)
  • DSS 0.07
  • SILO 0.19
  • MACD
  • DSS 0.01
  • SILO -0.05
  • Stochastic Oscillator
  • DSS 38.09
  • SILO 27.12

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: